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Exposure and sensitization to fungal allergens can promote the development and worsening of allergic
diseases. Although numerous species of fungi have been associated with allergic diseases in the litera-
ture, the signiﬁcance of fungi from the genera Alternaria, Cladosporium, Penicillium, Aspergillus, and
Malassezia has been well documented. However, it should be emphasized that the contribution of
different fungal allergens to allergic diseases is not identical, but species-speciﬁc.
Alternaria and Cladosporium species are considered to be important outdoor allergens, and sensiti-
zation and exposure to species of these genera is related to the development of asthma and rhinitis, as
well as epidemics of asthma exacerbation, including life-threatening asthma exacerbation. In contrast,
xerophilic species of Penicillium and Aspergillus, excluding Aspergillus fumigatus, are implicated in allergic
diseases as indoor allergens. A. fumigatus has a high capacity to colonize the bronchial tract of asthmatic
patients, causing severe persistent asthma and low lung function, and sometimes leading to allergic
bronchopulmonary aspergillosis. Malassezia are common commensals of healthy skin, although they are
also associated with atopic dermatitis, especially on the head and neck, but not with respiratory allergies.
Despite its importance in the management of allergic diseases, precise recognition of species-speciﬁc
IgE sensitization to fungal allergens is often challenging because the majority of fungal extracts exhibit
broad cross-reactivity with taxonomically unrelated fungi. Recent progress in gene technology has
contributed to the identiﬁcation of speciﬁc and cross-reactive allergen components from different fungal
sources. However, data demonstrating the clinical relevance of IgE reactivity to these allergen compo-
nents are still insufﬁcient.
Copyright © 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Fungi can have adverse effects on human health, causing
infection, IgE-mediated allergy, non-IgE-mediated hypersensitivity,
and toxicity/irritation. The incidence of fungal diseases has risen
rapidly over the last two decades, and fungal allergy is one of the
common health problems/medical conditions worldwide. It is
estimated that there are approximately 1.5 million species of fungi,
and numerous fungal species have been described as causes of
allergic diseases in the literature.1,2 The pathogenic signiﬁcance of
fungi from the genera Alternaria, Cladosporium, Penicillium,r Allergy and Rheumatology,
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The signiﬁcance of Candida, and Trichophyton have also been dis-
cussed, but still controversial. However, it should be emphasized
that the contribution of fungi to allergic diseases is species-speciﬁc,
with different fungal species leading to allergic diseases with
distinct presentations, which also vary according to the route and
speciﬁc episode of fungal allergen exposure. This review focuses on
the allergenicity of common environmental and commensal fungi
in humans, and on the species-speciﬁc clinical relevance of these
fungal allergens in allergic diseases.Outdoor environmental fungi
Cladosporium and Alternaria, which display some lesional vari-
ations, are two of the major genera of outdoor airborne fungi
worldwide.3e6 The outdoor concentration of fungal species from
these genera has been associated with epidemics of asthmavier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
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hara city in Japan10 demonstrated that Cladosporium and Alternaria
were the predominant genera, followed by Epicoccum spp., Aur-
eobasidium spp., Curvularia spp., and Ulocladium spp. Detection of
Cladosporium revealed two seasonal peaks, during the rainy season
(June) and the autumn (September to October), whereas Alternaria
was detected fromApril to October, but most frequently in the rainy
season (June).10Indoor environmental fungi
Although there also is some lesional variation, Cladosporium,
Penicillium, and Aspergillus spp. are reported to be the most com-
mon indoor airborne fungi.3,11e17 However, in the case of Clado-
sporium, because the indoor concentration is highly correlated with
the outdoor concentration,13 the primary source of Cladosporium is
considered to be the outdoor environment. A recent environmental
survey in Japan used an air sampler to investigate the proﬁle of
indoor airborne fungal spores.18 The frequencies of isolates of Cla-
dosporium spp., Penicillium spp., Aspergillus section restricti, and
Aspergillus versicolor were 100, 78, 84, and 59%, respectively.
Among all the isolated fungal species, the highest number of spores
was detected for Aspergillus conicus, a species of Aspergillus section
restricti. House dust (HD) also contains fungi, and the proﬁle of
fungi in HD is similar but not identical to that of airborne. In Japan,
the proﬁle of fungal spores isolated from HD was characterized by
high frequencies of Eurotium spp. (88%), A. versicolor (90%), and
Aspergillus section restricti (87%), and a relatively low frequency of
Penicillium spp.(30%).18 The abundance of Aspergillus and Penicil-
lium spores in the indoor environment may be explained by the
ﬁnding that although optimal fungal growth requires high hu-
midity, some xerophilic species of the genera Aspergillus and Peni-
cillium are able to survive in a dry environment.14,190%
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Fig. 1. Frequencies of positivity (%) to intradermal testing using fungal extracts among 1288 a
to fungi shown in ﬁg. A show statistically signiﬁcant decrease trend with age (p trend<0.001
yextracts purchased from Torii Pharmaceutical (Japan); yy and from HollisterStier (USA). OtPrevalence of fungal sensitization
The prevalence of fungal sensitization displays wide geograph-
ical variation.20,21 Data from the European Community Respiratory
Health Survey (ECRHS) demonstrated that among adults aged
20e44 years in the general population, the prevalence of positive
skin tests using Alternaria and Cladosporium extracts ranged from
0.2 to 14.4 %, and 0e11.9%, respectively.21
The frequencies of positivity to fungal allergens among adult
patients with asthma at Sagamihara National Hospital in Japan are
shown in Fig. 1. Sensitization to Malassezia, Alternaria, and Clado-
sporium tended to decrease with age, which is in accordance with
the general recognition that atopic asthma is more common in
younger patients.22 However, the frequency of Aspergillus fumigatus
did not decrease with age, most likely because sensitization to this
species is associated with severe persistent asthma with long dis-
ease duration.23 A notable proportion of the patients, approxi-
mately 10e15%, were positive for common indoor environmental
xerophilic fungi, in particular, Aspergillus restrictus, and Eurotium
spp. The frequencies of positive skin tests for these fungi did not
change with age, highlighting the potential signiﬁcance of these
indoor fungal species in middle-aged and elderly patients. This
ﬁnding is similar to that of a study by Chou et al.24 Although Candia
exhibits markedly high frequencies of positivity, the majority of
affected patients have negative serum IgE tests for Candida (data
not shown).Cross-reactivity of fungal allergens
Measurement of serum IgE antibodies (Abs) from crude extract
and/or a skin prick test using crude extract has been traditionally
performed as the standard test for diagnosis of allergies. However,
because of cross-reactivity between crude allergen extracts from0%
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dult patients with asthma at Sagamihara National Hospital. Frequencies of sensitization
for all six fungi), and those to fungi shown in ﬁg. B do not show any change with age.
her fungal extracts were cultured in-house.
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does not always indicate genuine sensitization. Species-speciﬁc IgE
reactivity is difﬁcult to conﬁrm using crude extracts alone, and this
represents a major problem for the evaluation of IgE tests in clinical
practice. More recently, allergenic molecules (allergen compo-
nents) that are either puriﬁed from their native sources or pro-
duced as recombinant proteins, have been introduced into the
battery of tests available for the diagnosis of allergic diseases.26e28
Molecular-based allergy (MA) diagnostics,29 formally known as
component-resolved diagnostics (CRD),30,31 is an approach used to
map the allergen sensitization of a patient at a molecular level,
using puriﬁed natural or recombinant allergenic molecules instead
of allergen extracts. One of the most important implications of MA
diagnostics is its ability to distinguish genuine sensitization from
sensitization due to cross-reactivity, following evaluation of the
sensitization proﬁle to speciﬁc allergens and pan-allergens.29
This review focuses on speciﬁc and cross-reactive allergens from
seven genera of common allergenic fungi. Cross-reactivity between
fungal allergens is largely explained by taxonomic relationships
between genera/species. Fig. 2 depicts the taxonomic relationships
among all the allergenic fungi registered in the World Health Or-
ganization and International Union of Immunological Societies
(WHO/IUIS) Allergen Nomenclature Sub-committee database
(http://www.allergen.org/).Fu
ng
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Fig. 2. Taxonomic relationships of allergenic fungi registered in the WHO/IUIS Allergen No
basis of Dictionary of the Fungi, 10th Edition, Wallingford, UK: CABI Publishing (http://wwAlternaria
Alternaria alternata, which commonly grows on vegetation, is
the most common species of the genus Alternaria, and it is the
major environmental allergen associated with asthma32e35 and
allergic rhinitis.36 Alternaria spp. are generally considered to be
outdoor fungi,15,37 although they also exist in indoor environ-
ments.38,39 Airborne outdoor Alternaria spores are detectable from
May to November, with the highest levels occurring in cultivated
areas containing grassland and grain.40,41 A study using personal air
samplers and nasal air samplers demonstrated that a greater
number of spores were inhaled in an outdoor than an indoor
environment, an effect that was accentuated by physical activity.42
Spores from Alternaria spp. are larger than those from most other
fungi, at approximately 20e40 mm in diameter,7 and tend to be
easily trapped in the nasal cavity. However, it has been reported
that spores on cereal crops and grass may be broken into small
fragments, presumably because of mechanized harvesting.7,43,44
The clinical signiﬁcance of A. alternata as the respiratory allergen
has been well documented. Studies have revealed a strong associ-
ation between sensitization to Alternaria spp. and the presence of
asthma32,33,35,45e47 or allergic rhinitis,36 as well as the severity of
asthma.48e50 In addition, sensitization and exposure to Alternaria
has been associated with epidemics of severe asthma exacerbation,DothideomyceƟdae Capnodiales Cladosporiaceae Cladosporium
PleosporomyceƟdae Pleosporales Pleosporaceae
Alternaria
Curvularia
Epicoccum
EuroƟomyceƟdae
EuroƟales Trichocomaceae
Aspergillus
Penicillium
Onygenales Arthrodermataceae Trichophyton
HypocreomyceƟdae Hypocreales
Nectriaceae Fusarium
incertae sedis Stachybotrys
SaccharomyceƟdae Saccharomycetales incertae sedis Candida
incertae sedis Sporidiobolales incertae sedis Rhodotorula
incertae sedis Malasseziales Malasseziaceae Malassezia
AgaricomyceƟdae Agaricales
Agaricaceae Coprinus
Strophariaceae Psilocybe
Schizophyllaceae Schizophyllum
Mucorales Rhizopodaceae Rhizopus
Subclass Family GenusOrder
menclature Sub-committee database (http://www.allergen.org/). Classiﬁcation on the
w.speciesfungorum.org/).
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contributory factor to high levels of fungal spores and epidemics of
asthma exacerbation.4 Before a thunderstorm, an increase in air
temperature and ozone concentration is observed, which is
accompanied by a substantial increase in spore concentrations.5 A
study in the UK in patients with Alternaria sensitization revealed a
correlation between fragmented Alternaria spores, presumably
caused by mechanized harvesting, and epidemics of acute asthma
exacerbation after thunderstorms.7 Data from asthmatic patients
identiﬁed in the ECRHS also demonstrate that sensitization to
Alternaria is associated with a higher risk of asthma attacks during
May to August in Southern Europe, and during July and August in
Northern Europe.53
Alternaria can occur in indoor environments, especially under
humid conditions, such as cervices in bathrooms and walls with
dew condensation.17 However, the clinical relevance of Alternaria
spp. as indoor fungi has not been deeply studied. Because indoor
Alternaria concentrations are strongly inﬂuenced by outdoor con-
centrations,13 the independent contribution of indoor Alternaria
concentrations is difﬁcult to determine. However, a recent birth
cohort study in Boston revealed a signiﬁcant relationship between
indoor dust-borne Alternaria at the age of 2e3 months and the
frequency of wheezes, by one year old even after adjustment for
outdoor airborne Alternaria concentrations.54 These data suggest
that Alternaria in HD may be an important environmental allergen,
in particular, for children.38
Although many allergenic proteins have been identiﬁed and
approved by theWHOeIUISAllergenNomenclature Sub-committee
(Table 1), Alt a 1 is considered to be only speciﬁc allergen compo-
nent for the genuine Alternaria (or Pleosporaceae family)
allergy.55e59 Spore germination promotes the release of allergens,
including Alt a 1, from A. alternata.60 A recent study using immu-
nogold electron microscopy demonstrated that Alt a 1 was mainly
localized in the cell wall of airborne spores, which may explain the
high clinical relevance of Alt a 1 as a respiratory allergen.61 Alt a 1
has been reported to cross-react with homologous fungal proteins
from members of the Pleosporaceae family such as Stemphylium,
Ulocladium, and Curvularia.1,59,62 In contrast, allergenic proteins
other than Alt a 1 exhibit a high sequence similarity with homolo-
gous proteins from taxonomically unrelated fungi. Thus, the diag-
nostic and clinical relevance of allergenic proteins other than Alt a 1
with respect to Alternaria allergy is unclear.
Cladosporium
Cladosporium is one of the most abundant genera of environ-
mental fungi worldwide, and Cladosporium herbarum is one of theTable 1
Allergenic proteins from fungi of genus Alternaria approved by WHO/IUIS Allergen
Nomenclature Sub-committee.
Species Allergen Biological activity Molecular weight
Alternaria
alternata
Alt a 1 16.4 and 15.3 band
(30 non-red)
Alt a 3 Heat shock protein 70
Alt a 4 Disulﬁde isomerase 57
Alt a 5 Ribosomal protein P2 11
Alt a 6 Enolase 45
Alt a 7 YCP4 protein 22
Alt a 8 Mannitol dehydrogenase 29
Alt a 10 Aldehyde dehydrogenase 53
Alt a 12 Acid ribosomal protein P1 11
Alt a 13 Glutathione-S-transferase 26
Alt a 14 Manganese superoxide
dismutase
24 kDa (reducing)
Alt a 15 Serine protease 58 kDmost common species to be isolated. Similar to Alternaria, Clado-
sporium is generally recognized as an outdoor fungus,4,15 but it is
frequently detected in indoor environments.38,39,63 A strong cor-
relation between indoor and outdoor Cladosporium concentrations
has also been reported.39,64 The clinical relevance of Cladosporium
as a respiratory allergen resembles that of Alternaria,65e67 whereas
the contribution of this genus to the pathogenesis of asthma ap-
pears to be a little weaker than that of Alternaria. Data from the
ECHRS indicate that the prevalence of positive skin prick tests for
Cladosporium is 1.7% (ranging from 0 to 11.9%), which is lower than
that for Alternaria (3.3%, ranging from 0.2 to 14.4%).21 The threshold
concentration for evoking allergic symptoms is estimated to be
3,000 spores/m3 air for Cladosporium, which is substantially higher
than that for Alternaria (100 spores/m3 air).43,68 The size of Clado-
sporium spores varies over a wide range, between 3 and
70  2e56 mm.69
Although many allergenic proteins have been identiﬁed and
approved by the WHOeIUIS Allergen Nomenclature Sub-
committee (Table 2), no speciﬁc major allergen components have
been identiﬁed for Cladosporium allergies.With the exception of Cla
h 8, all of the registered allergens are cross-reactive minor aller-
gens.1 Cla h 8, an NADP-dependent mannitol dehydrogenase, is
recognized by 57% of Cladosporium herbarum-sensitized patients,70
and it has 75% sequence similarity with Alt a 8, an NADP-dependent
mannitol dehydrogenase from A. alternata.71 Presumably due to the
cross-reactive nature of identiﬁed Cladosporium allergens, mono-
sensitization to Cladosporium appears to be relatively rare.72Penicillium
Penicillium is the blue or blue-green mold found on fruits and
vegetables, and it is used for the production of blue mold cheese.
While Penicillium is frequently isolated both in indoor and outdoor
environments,13,15 many studies have focused on the signiﬁcance of
Penicillium as an indoor mold allergen.11,73,74 Indoor environmental
factors, including inadequate heating and ventilation, the presence
of pets, water leaks, and low sun exposure, are known to increase
the concentrations of airborne Penicillium.14 Results for Alternaria
and Cladosporium spp. indicate that indoor concentrations are
highly correlated with outdoor concentrations, whereas for Peni-
cillium spp. this correlation is not always observed.13 A birth cohort
study in Connecticut and western Massachusetts evaluated the
effect of exposure to speciﬁc genera of indoor airborne fungi,
collected with a portable air sampler, on the incidence of respira-
tory symptoms. Although Cladosporium (61%) were most frequent
followed by Penicillium (41%), airborne levels of Cladosporiumwere
not related to an increased risk of wheeze. In contrast, the highest
concentration of Penicillium was associated with a higher rate of
incident wheeze (RR, 2.15, 95%Cis, 1.34e3.46), and persistent coughTable 2
Allergenic proteins from fungi of the genus Cladosporium approved by theWHO/IUIS
Allergen Nomenclature Sub-committee.
Species Allergen Biological activity Molecular
weight
Cladosporium
cladosporioides
Cla c 9 Vacuolar serine protease 36
Cla c 14 Transaldolase 36.5
Cladosporium
herbarum
Cla h 2 45
Cla h 5 Acid ribosomal protein P2 11
Cla h 6 Enolase 46
Cla h 7 YCP4 protein 22
Cla h 8 Mannitol dehydrogenase 28
Cla h 9 Vacuolar serine protease
Cla h 10 Aldehyde dehydrogenase 53
Cla h 12 Acid ribosomal protein P1 11
Table 4
Allergenic proteins from fungi of the genus Aspergillus approved by the WHO/IUIS
Allergen Nomenclature Sub-committee.
Species Allergen Biological activity Molecular
weight
Aspergillus ﬂavus Asp ﬂ 13 Alkaline serine protease 34
Aspergillus fumigatus Asp f 1 Mitogillin family 18
Asp f 2 37
Asp f 3 Peroxysomal protein 19
Y. Fukutomi, M. Taniguchi / Allergology International 64 (2015) 321e331 325(RR, 2.06, 95%Cis, 1.31e3.24).75 Another cross-sectional study by
the same authors conﬁrmed the association of sensitization and
exposure to indoor airborne Penicillium with wheeze and the
severity of asthma.76
Although numerous allergens from different Penicillium species
have been identiﬁed and approved by the WHOeIUIS Allergen
Nomenclature Sub-committee (Table 3), no species- or genus-
speciﬁc major allergen components have been documented for
Penicillium allergies. The major allergens from Penicillium spp. are
alkaline and vacuolar serine proteases, which are referred to as
group 13 and group 18 allergens, respectively.1,77,78 These proteases
exhibit high sequence similarity with homologous allergens from A.
fumigatus (Asp f 13, Asp f 18). A study in Taipei demonstrated that
17% of asthmatic patients are positive to puriﬁed Pen ch 13 by IgE-
immunoblotting, and the frequency of positivity increases with age,
reaching 42% among patients aged over 70 years, indicating that
Penicillium is of higher relevance to adult asthma than childhood
asthma.24 Because of the cross-reactive nature of identiﬁed Peni-
cillium allergens, mono-sensitization to Penicillium appears to be
relatively rare.72 Hypersensitivity pneumonitis induced by Penicil-
lium species has also been reported.79e81
Aspergillus
The genus Aspergillus includes more than one hundred species
that are distributed ubiquitously in the environment. Human dis-
orders caused by the Aspergillus include allergic asthma and/or
rhinitis, allergic bronchopulmonary mycosis (ABPM),82 allergic
rhinosinusitis,83,84 hypersensitivity pneumonitis,85e87 aspergil-
loma,88 and invasive aspergillosis. ABPM is a pulmonary hyper-
sensitivity disease characterized by sensitization to fungi,
uncontrolled asthma, recurrent transient radiographic inﬁltrate,
peripheral and pulmonary eosinophilia, and bronchiectasis.6,82,89,90
A. fumigatus is the most common causal pathogen for ABPM. In
addition, it is frequently isolated from the respiratory tract of pa-
tients with asthma who do not meet the criteria for allergic bron-
chopulmonary aspergillosis (ABPA),23,91 and also from patients
with respiratory diseases other than asthma, including cystic
ﬁbrosis,92 chronic obstructive pulmonary disease,93 tuberculosis-
related ﬁbrocavity disease,94,95 and occasionally in the respiratory
tract of healthy individuals.23 The pathogenic capacity of A. fumi-
gatus is related to its pronounced thermotolerance,96 whichTable 3
Allergenic proteins from fungi of the genus Penicillium approved by the WHO/IUIS
Allergen Nomenclature Sub-committee.
Species Allergen Biological activity Molecular
weight
Penicillium
brevicompactum
Pen b 13 Alkaline serine protease 33
Pen b 26 Acidic ribosomal prot. P1 11
Penicillium
chrysogenum
Pen ch 13 Alkaline serine protease 34
Pen ch 18 Vacuolar serine protease 32
Pen ch 20 N-acetyl-glucosaminidase 68
Pen ch 31 Calreticulin
Pen ch 33 16
Pen ch 35 Transaldolase 36.5
Penicillium
citrinum
Pen c 3 Peroxysomal membrane protein 18
Pen c 13 Alkaline serine protease 33
Pen c 19 Heat shock protein P70 70
Pen c 22 Enolase 46
Pen c 24 elongation factor 1 beta
Pen c 30 Catalase 97
Pen c 32 Pectate lyase 40
Penicillium
crustosum
Pen cr 26 60S acidic ribosomal
phosphoprotein P1
11 kDa
Penicillium
oxalicum
Pen o 18 Vacuolar serine protease 34enables them to grow at human body temperature, and its small
spore size (approximately 2e3 mm),97 which enables transfer to the
terminal airways. Despite its importance as a fungus that colonizes
the human respiratory tract, A. fumigatus is not a dominant species
in either indoor or outdoor environments. The most common
environmental fungal species among the genus Aspergillus is not A.
fumigatus, but Aspergillus niger, A. restrictus, A. versicolor, and
Aspergillus ochraceous.18,38,64,74 Studies have demonstrated that the
clinical relevance of the association between exposure to indoor
Aspergillus spp. and the risk of asthma12,74,98 resembles that of
Penicillium spp., which is a closely related fungus in the tax-
onomical classiﬁcation.
Several studies have found that IgE sensitization to A. fumigatus
and/or colonialization of A. fumigatus in the respiratory tract of
asthmatic patients is associated with reduced lung function23,91,99
and severe disease.100 The possible role of antifungal therapy in
the treatment of fungal allergic asthma has also been reported.101
Another study demonstrated that although A. fumigatus is not
abundant in the indoor environment, isolation of this species from
sputumwas related to higher airborne concentrations of the fungus
in the homes of asthmatic patients, suggesting that the home
environment should also be considered as a source of fungal
exposure.102 Therefore, housing intervention may be necessary for
the management of fungal allergen-sensitized severe asthma.14
Numerous allergens from Aspergillus have been identiﬁed and
approved by the WHOeIUIS Allergen Nomenclature Sub-
committee (Table 4). Some of these allergen components are spe-
cies- or genus-speciﬁc, while others are pan-allergens that display
cross-reactivity beyond the family or order. Asp f 1 has been
identiﬁed as an 18-kD allergen of mitogillin family, which is almost
identical to restrictocin cloned from A. restrictus,103 and is a species-
speciﬁc major allergen for A. fumigatus.104 The Asp f 1 allergen is notAsp f 4 30
Asp f 5 Metalloprotease 40
Asp f 6 Mn superoxide dismutase 26.5
Asp f 7 12
Asp f 8 Ribosomal protein P2 11
Asp f 9 34
Asp f 10 Aspartate protease 34
Asp f 11 Peptidyl-prolyl isomerase 24
Asp f 12 Heat shock protein P90 90
Asp f 13 Alkaline serine protease 34
Asp f 15 16
Asp f 16 43
Asp f 17
Asp f 18 Vacuolar serine protease 34
Asp f 22 Enolase 46
Asp f 23 L3 ribosomal protein 44
Asp f 27 Cyclophilin 18
Asp f 28 Thioredoxin 13
Asp f 29 Thioredoxin 13
Asp f 34 PhiA cell wall protein 20
Aspergillus niger Asp n 14 Beta-xylosidase 105
Asp n 18 Vacuolar serine protease 34
Asp n 25 3-phytase B 66e100
Aspergillus oryzae Asp o 13 Alkaline serine protease 34
Asp o 21 TAKA-amylase A 53
Aspergillus versicolor Asp v 13 Extracellular alkaline serine
protease
43 kDa
Table 5
Allergenic proteins from fungi of the genus Malassezia approved by the WHO/IUIS
Allergen Nomenclature Sub-committee.
Species Allergen Biological activity Molecular
weight
Malassezia
furfur
Mala f 2 Peroxysomal membrane protein 21
Mala f 3 Peroxysomal membrane protein 20
Mala f 4 Mitochondrial malate dehydrogenase 35
Malassezia
sympodialis
Mala s 1
Mala s 5
Mala s 6 Cyclophilin
Mala s 7
Mala s 8
Mala s 9
Mala s 10 Heat shock protein 70 86
Mala s 11 Manganese superoxide dismutase 23
Mala s 12 Glucose-methanol-choline (GMC)
oxidoreductase
67
Mala s 13 Thioredoxin 13
Y. Fukutomi, M. Taniguchi / Allergology International 64 (2015) 321e331326present in spores, being produced after germination and growth of
the fungi,105 and it is almost undetectable in HD extracts.106 Thus,
respiratory sensitization to airborne Asp f 1 in the indoor envi-
ronment seems to be uncommon, and patients who develop anti-
body responses to Asp f 1 have been exposed to A. fumigatuswhich
has germinated in their respiratory tract.106 A speciﬁc mAb-based
ELISA for Asp f 1 has been shown to be a useful tool for standard-
ization and quality control of A. fumigatus allergenic products.107
Asp f 2 is a species-speciﬁc major allergen of A. fumigatus, with a
frequency of sensitization of 96%,100,108e110 while Asp f 4 is another
well-described speciﬁc allergen, with a frequency of sensitization
of 92%.111 On the contrary, Asp f 3112, Asp f 6113, Asp f 8114, Asp f
12115, Asp f 22116, and Asp f 27117, which correspond to peroxisomal
membrane protein (PMP), manganese superoxide dismutase
(MnSOD), ribosomal protein P2, heat shock protein 90, enolase, and
cyclophilin from A. fumigatus, exhibit high similarity and identity
with homologous proteins from fungi of genera other than Asper-
gillus.112,118,119 While many studies111,120e122 have focused on the
clinical relevance of sensitization to panels of the A. fumigatus
allergic proteins, Asp f 1, f 2, f 3, f 4, and f 6, as diagnostic markers of
ABPA, the results are controversial.90
Although some allergenic molecules, such as Asp f 9113 and the
more recently identiﬁed Asp f 34123, have a relatively high sequence
speciﬁcity for A. fumigatus and a high prevalence of sensitization
among the ABPA population, indicating that these allergens are of
clinical importance, the number of studies demonstrating their
clinical relevance has been limited to date. Asp n 14 and Asp n 25
from A. niger, and Asp o 21 from Aspergillus orizae have been
identiﬁed as allergenic proteins causing occupational respiratory
allergies.
It is important to recognize that most of the allergenic compo-
nents from A. fumigatus have been identiﬁed using sera from pa-
tients with ABPA. The importance of other allergenic proteins from
the genus Aspergillus as environmental respiratory allergens has
not been well studied. According to clinical data from the author's
hospital, the concordance between positive intradermal tests to A.
fumigatus and A. restrictus is low (data not shown), which indicates
that current techniques for serum IgE or skin tests using extracts
from A. fumigatusmay not be used for the diagnosis of sensitization
to environmental Aspergillus.
Malassezia
Malassezia yeasts (formally known as Pityrosporum orbiculare/
ovale) are commensals of healthy human skin, but are also associ-
ated with pityriasis versicolor, seborrheic dermatitis, and atopic
dermatitis.124,125 All the species within the genus, with the excep-
tion of Malassezia pachydermatis, are lipid-dependent due to their
inability to initiate de novo synthesis of C14 or C16 fatty acids.126
Thus, Malassezia spp. do not exist in the external atmosphere.
Although many species have been identiﬁed within the genus, the
most commonly detected species on healthy human skin are
Malassezia sympodialis, M. globose, and Malassezia restricta.
Malassezia spp allergens have been described as important
exacerbating factors for atopic dermatitis (AD), in particular, head
and neck-type adult AD, but they have not been associated with
respiratory allergies. Studies have demonstrated the strong corre-
lation between speciﬁc IgE Abs to Malassezia and the presence of
AD,127e129 as well as between IgE Abs toMalassezia and the severity
of AD130e132 and dermatitis on head and neck.131,133 The frequency
of sensitization to Malassezia among the head and neck-type AD
population is relatively high, ranging from 55% to 68%.132,134,135
Improvements in head and neck-type AD after antifungal therapy
have been documented.136e138 Similar to healthy individuals,
M. sympodialis, M. globose, and M. restricta are also commonlydetected species on the skin of AD patients. However, in contrast to
the strong IgE response of AD patients to Malassezia, a study re-
ported that the population density ofMalassezia on lesional AD skin
was lower than non-lesional AD or healthy skin.139 Furthermore, a
more recent study indicated that non-Malassezia yeast microbiota
of AD patients is more diverse than that of healthy individuals.140
Many allergenic proteins from fungi of the genus Malassezia
have been identiﬁed and approved by the WHO/IUIS Allergen
Nomenclature Sub-committee (Table 5). Malassezia species pro-
duce complex allergens that contain both common and species-
speciﬁc allergen sequences.141,142 It is hypothesized the variation
in Malassezia microﬂora on the skin surface of AD patients is re-
ﬂected by the heterogeneity of sensitivity toMalassezia spp of each
AD patient. Thus, serum IgE Ab tests using a mixture of
M. sympodialis, M. globose, and M. restricta are commercially avail-
able and used in clinical practice. Crude extracts of Malassezia spp.
also contain allergenic proteins that exhibit high sequence simi-
larity to proteins from fungi of genera other than Malassezia,
including PMP (Mala f 2, and 3),118 cyclophiline (Mala s 6),117,143,144
heat shock protein 70 (Mala s 10),145 MnSOD (Mala s 11),145 and
thioredoxin (Mala s 13).146 As a result, cross-reactivity is observed
between crude extracts of Malassezia spp. and those of fungi from
genera other than Malassezia. Mannan, a polysaccharide, is also
known to be associated with IgE cross-reactivity beyond the
genus.147 In contrast, Mala s 1, 7, 8, and 9 are considered to be
speciﬁc allergens with unique sequences.129,144,148,149
Casagrande et al. investigated the frequency of sensitization to a
panel of recombinant M. sympodialis allergens (rMala s 1 and 5e9)
in 51 patients with atopic eczema who were positive for IgE Abs to
crude M. sympodialis (ImmunoCAP m70). Analysis by ELISA indi-
cated that the frequencies of positivity for IgE Abs to rMala s 1, 5, 6,
7, 8, and 9 were 39, 47, 55, 10, 31, and 61%, respectively, indicating
that Mala s 1, 5, 6 and 9 are the predominant allergenic
components.129
Candida
Candida is a genus of yeasts, with many species being com-
mensals of the skin, and the gastrointestinal and genitourinary
tracts. Candida albicans is the most frequently isolated species and
many studies have suggested that it plays a role in the pathogenesis
of allergic diseases. However, the clinical signiﬁcance of C. albicans
as an allergen causing allergic diseases remains controversial. Many
studies have shown the association between IgE sensitization to C.
albicans, and the presence and severity of AD.150e153 In addition, C.
albicans is more frequent in the gastrointestinal tract of patients
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the signiﬁcant cross-reactivity between C. albicans and Malassezia
allergens,155,156 the clinical relevance of speciﬁc IgE sensitization to
C. albicans, independent from that to Malassezia, also remains a
matter of debate.
The clinical signiﬁcance of C. albicans as a causal allergen for
respiratory allergies is much less clear than for AD.157 C. albicans is
frequently isolated from the respiratory tract. However, a study in
patients with cystic ﬁbrosis demonstrated that although sensiti-
zation to and colonialization of C. albicans was common, colonial-
ization and sensitization were not correlated.92 While some
asthmatic patients who are IgE-sensitized to C. albicans experience
an immediate bronchial response after inhalation of C. albicans
extract,158 its speciﬁc signiﬁcance beyond fungal cross-reactivity is
yet to be clariﬁed. Asero et al. reported on the clinical features of
adult patients with respiratory allergies monosensitized to C. albi-
cans.159 The proportion of males and females was equally distrib-
uted, the mean age was 58 years old, which was higher than atopic
controls, and 44% had nasal polyposis. The same author demon-
strated that the higher frequency of sensitization to C. albicans in
patients with nasal polyposis compared with the general subjects
with respiratory allergy.160 One study examined the association
between recurrent vaginal candidiasis and atopy in women. Atopy,
deﬁned by the presence of allergic respiratory diseases or a positive
skin prick test to at least one allergen, was associated with recur-
rent vaginal candidiasis, whereas speciﬁc IgE to C. albicans was
not.161 Other studies have revealed an association between IgE
sensitization to C. albicans and chronic urticaria,162 as well as a high
frequency of sensitization to C. albicans in eosinophilic
esophagitis.163
Several allergenic proteins from fungi of the genus Candida
have been approved by the WHO/IUIS Allergen Nomenclature Sub-
committee. Cand a 1 is a 40-kD alcohol dehydrogenase from C.
albicans. Using sera from 30 asthmatic patients with a positive
skin test and IgE Abs to C. albicans, IgE immunoblotting of C.
albicans extract showed that Cand a 1 had the highest frequency,
being recognized by 23 (77%) patients.164 Cand a 3 is 20-kD
peroxisomal protein, which has 62% sequence identity with a
hypothetical protein (YDR533c) from Saccharomyces cerevisiae.165
Nine (56%) of 16 asthmatic sera with positive serum IgE Abs
tests to C. albicans displayed positivity to Cand a 3 in IgE immu-
noblotting. Cand b 2 is a 20-kD peroxisomal membrane protein
from Candida boidnii, which displays cross-reactivity with PMP
from A. fumigatus, Asp f 3 112. Secreted aspartyl proteinase (SAP;
formally known as C. albicans acid protease) is an extracellular
hydrolytic enzyme secreted by C. albicans and some pathogenic
Candida species, and it is a key determinant of the virulence of C.
albicans.166 Akiyama et al. demonstrated that the signiﬁcance of
SAP as an allergen for respiratory and mucosal allergy after
conjunctival and bronchial provocation with the puriﬁed SAP
enzyme.167,168 Isolated late skin and bronchial responses to puri-
ﬁed SAP were also observed for nonatopic asthmatics whose pe-
ripheral blood mononuclear cells released IL-5 upon incubation
with puriﬁed SAP, which indicated the possible role of SAP as a T-
cell allergen for nonatopic asthma.169
Trichophyton
Fungi in the genus Trichophyton are known as the causal
pathogen of dermatophytosis, a fungal infection of the skin, hair,
and nails. Trichophyton rubrum and Trichophyton mentagrophytes
are the most common pathogens in the genus. Although Tricho-
phyton spp. are only found at low concentrations in indoor and
outdoor environments, sensitization to Trichophyton is relatively
common among the general atopic population.72 This isattributed to the high prevalence of dermatophytosis in the
general population.170e172
High levels of IgE Abs to Trichophyton are found in patients with
trichophytosis, regardless of atopy,173,174 indicating that Tricho-
phyton infection, not respiratory exposure, is the major determi-
nant of an IgE response to Trichophyton. However, it has been
suggested that tinea infection/sensitization plays a role in the
pathogenesis of asthma and rhinitis.175e178 In a placebo-controlled
clinical trial by Ward et al., an improvement in asthma symptoms,
peak ﬂow, and steroid use was observed among patients with late-
onset asthma who had tinea infection after oral ﬂuconazole treat-
ment.179 However, the route of exposure to Trichophyton allergens
in such Trichophyton-infected patients has not been identiﬁed. A
few reports have suggested the possible role of inhaled Tricho-
phyton in the pathogenesis of asthma or rhinoconjunctivitis among
subjects without Trichophyton infection.180 Occupational exposure
to airborne Trichophyton in nail dust has been shown to induce
nasal and eye symptoms in chiropodists.181 Sensitization to Tri-
chophyton is also reported to be a risk factor for more severe disease
among the general asthmatic population.182
Some allergenic proteins from fungi of the genus Trichophyton
have been identiﬁed and approved by the WHO/IUIS Allergen
Nomenclature Sub-committee. Tri t 1 is a 30-kD, exo 1,3-beta-
glucanase that causes an immediate hypersensitivity skin reaction.
It is a major allergen of Trichophyton tonsurans, with the prevalence
of sensitization being 73% (22 of 30) in patients with asthma
rhinitis or urticaria who were sensitized to Trichophyton
extract.183e185 Tri t 4 is an 83-kD serine protease that is associated
with delayed hypersensitivity skin reactions, but can also cause
immediate hypersensitivity skin reactions.186 Tri r 2, from the
T. rubrum species, is as a 29-kD serine protease that elicits imme-
diate and delayed-type hypersensitivity skin reactions in different
individuals.187,188 Tri r 4, an 85-kD serine protease, has also been
identiﬁed but it does not elicit skin test reactivity.188Conclusion
The clinical and diagnostic relevance of allergens from seven
common genera of fungi has been reviewed. Recent progress in
gene technology has greatly contributed to the identiﬁcation of
species-speciﬁc and cross-reactive allergic molecules from
different allergenic fungal sources. However, data verifying the
clinical and diagnostic relevance of IgE reactivity to these allergens
are insufﬁcient. Recent studies from Japan have suggested the
possible contribution of other fungal allergen sources, including
Schizophyllum commune189,190 and Bjerkandera adusta191 from
basidiomycetous fungi,192,193 to the pathogenesis of respiratory
allergy, cough, and ABPM. Data regarding the species-speciﬁc
impact of these fungi on the general allergic population are also
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